Peak Bio, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Peak Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2024.
  • Peak Bio, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -109 %, a 11.2% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -109 +13.8 +11.2% Sep 30, 2024
Q2 2024 -109 +9.66 +8.12% Jun 30, 2024
Q1 2024 -110 +6.29 +5.4% Mar 31, 2024
Q4 2023 -112 -4.72 -4.39% Dec 31, 2023
Q3 2023 -123 -57.7 -88.8% Sep 30, 2023
Q2 2023 -119 -31.1 -35.5% Jun 30, 2023
Q1 2023 -116 +817 +87.5% Mar 31, 2023
Q4 2022 -108 +1.9K +94.6% Dec 31, 2022
Q3 2022 -65 +2.45K +97.4% Sep 30, 2022
Q2 2022 -87.8 Jun 30, 2022
Q1 2022 -934 Mar 31, 2022
Q4 2021 -2.01K Dec 31, 2021
Q3 2021 -2.51K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.